Compared to Estimates, Cinemark (CNK) Q1 Earnings: A Look at Key Metrics

Cinemark Holdings (CNK) reported $540.7 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 6.7%. EPS of -$0.32 for the same period compares to $0.19 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $519.59 million, representing a surprise of +4.06%. The company has not delivered EPS surprise, with the consensus EPS estimate being -$0.32.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Cinemark performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Average ticket price - U.S. Operating Segment: $10.08 versus $9.87 estimated by three analysts on average. Average ticket price - International Operating Segment: $3.53 versus $3.62 estimated by three analysts on average. Concession revenues per patron - U.S. Operating Segment: $7.98 compared to the $7.78 average estimate based on three analysts. Concession revenues per patron - International Operating Segment: $2.88 compared to the $2.87 average estimate based on three analysts. Revenue- U.S. Operating Segment- Admissions: $207.60 million compared to the $205 million average estimate based on three analysts. The reported number represents a change of -10.4% year over year. Revenue- International Operating Segment- Admissions: $56.50 million compared to the $51.54 million average estimate based on three analysts. The reported number represents a change of -2.6% year over year. Revenue- U.S. Operating Segment- Concession: $164.40 million versus $161.53 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -8% change. Revenue- International Operating Segment- Concession: $46 million compared to the $40.83 million average estimate based on three analysts. The reported number represents a change of +0.9% year over year. Revenue- U.S. Operating Segment- Other: $45.10 million versus $41.54 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -3.2% change. Revenue- Admissions: $264.10 million compared to the $259.33 million average estimate based on five analysts. The reported number represents a change of -8.9% year over year. Revenue- Other: $66.20 million versus $61.03 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +1.5% change. Revenue- Concession: $210.40 million versus $205.44 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -6.2% change. View all Key Company Metrics for Cinemark here>>>Shares of Cinemark have returned +19.6% over the past month versus the Zacks S&P 500 composite's -0.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cinemark Holdings Inc (CNK): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks